Greenwich Lifesciences Inc. recently announced a change in its certifying accountants. On July 19, 2025, the company's audit committee decided to dismiss RBSM LLP as the independent registered public accounting firm and appointed MaloneBailey LLP to audit its consolidated financial statements for the year ending December 31, 2025. RBSM's reports on the company's financial statements for 2023 and 2024 did not contain any adverse opinions or disclaimers. However, the company did note material weaknesses in its internal control over financial reporting during those years. No disagreements or reportable events were cited in connection with RBSM's dismissal. The transition to MaloneBailey is effective immediately.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。